These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9192775)

  • 1. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
    Melnyk A; Rodriguez A; Pugh WC; Cabannillas F
    Blood; 1997 Jun; 89(12):4514-20. PubMed ID: 9192775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
    Rüdiger T; Weisenburger DD; Anderson JR; Armitage JO; Diebold J; MacLennan KA; Nathwani BN; Ullrich F; Müller-Hermelink HK;
    Ann Oncol; 2002 Jan; 13(1):140-9. PubMed ID: 11863096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
    Lee SS; Cho KJ; Kim CW; Kang YK
    Histopathology; 1999 Oct; 35(4):345-54. PubMed ID: 10564389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).
    Gisselbrecht C; Gaulard P; Lepage E; Coiffier B; Brière J; Haioun C; Cazals-Hatem D; Bosly A; Xerri L; Tilly H; Berger F; Bouhabdallah R; Diebold J
    Blood; 1998 Jul; 92(1):76-82. PubMed ID: 9639502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
    Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
    Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification.
    Kim K; Kim WS; Jung CW; Im YH; Kang WK; Lee MH; Park CH; Ko YH; Ree HJ; Park K
    Eur J Cancer; 2002 Jan; 38(1):75-81. PubMed ID: 11750843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation.
    Pittaluga S; Bijnens L; Teodorovic I; Hagenbeek A; Meerwaldt JH; Somers R; Thomas J; Noordijk EM; De Wolf-Peeters C
    Blood; 1996 May; 87(10):4358-67. PubMed ID: 8639796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
    Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
    Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.
    Savage KJ; Chhanabhai M; Gascoyne RD; Connors JM
    Ann Oncol; 2004 Oct; 15(10):1467-75. PubMed ID: 15367405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
    Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
    Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.
    Greer JP; Macon WR; Lamar RE; Wolff SN; Stein RS; Flexner JM; Collins RD; Cousar JB
    J Clin Oncol; 1995 Jul; 13(7):1742-50. PubMed ID: 7602364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aggressive peripheral T-cell lymphomas: 2013.
    Armitage JO
    Am J Hematol; 2013 Oct; 88(10):910-8. PubMed ID: 24078271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.
    Karakas T; Bergmann L; Stutte HJ; Jäger E; Knuth A; Weidmann E; Mitrou PS; Hoelzer D
    Leuk Lymphoma; 1996 Dec; 24(1-2):121-9. PubMed ID: 9049968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
    Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
    Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
    Visco C; Medeiros LJ; Jones D; Smith T; Rodriguez MA; McLaughlin P; Romaguera J; Cabanillas F; Sarris AH
    Ann Oncol; 2002 Aug; 13(8):1290-9. PubMed ID: 12181254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.
    López-Guillermo A; Cid J; Salar A; López A; Montalbán C; Castrillo JM; González M; Ribera JM; Brunet S; García-Conde J; Fernández de Sevilla A; Bosch F; Montserrat E
    Ann Oncol; 1998 Aug; 9(8):849-55. PubMed ID: 9789607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
    Tsartsidze E; Betaneli M
    Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.